Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle.
We are trusted experts in R&D, diagnostic services, API manufacture, formulation development, clinical trial supply services and technologies through to commercial-scale manufacture and distribution.
We are recognized as an industry leader in client service, providing understanding, experience and knowledge to our clients as we work together to advance human health.
Almac is trusted by the leading global biopharma companies to provide crucial services across their drug development projects. In the last 5 years alone, we have contributed to over 50% of all FDA approved New Molecular Entities (NMEs) and are currently supporting 30% of EU approved /pre-registered Gene therapy products.
A privately owned organization, Almac has grown organically over the past five decades, employing over 7,000 highly skilled employees across 18 facilities in Europe, North America, and Asia. Learn more about us here.
Our History
For over 50 years, Almac has supported the global Biopharmaceutical industry with their drug development activities and bringing new drugs to market to advance human health.
The strategy and activities outlined within this report demonstrate Almac Group's current and future commitment to long-term corporate sustainability and positive corporate impact.
Almac is a global provider of pharmaceutical support services with thousands of employees situated throughout its global facilities. It is Almac’s policy to conduct all business in an honest and ethical manner.
Northern Ireland lost its most passionate, visionary and generous man. Sir Allen McClay (Allen, as he preferred to be called) passed away on Tuesday 12th January, 2010.
The Almac Group is a group of companies operating in the highly regulated and risk-averse pharmaceutical and biotech sectors. We adopt this same low risk strategy in our approach to our tax affairs and tax strategy.
Almac Group is committed to carrying out its business of ethical pharmaceutical products manufacture and services provision in a manner which will not harm its employees, customers, contractors, visitors, neighbors or the environment.
Almac Group is committed to governance of procurement aligned with creating an environment intolerant to criminal conduct, such as any form of modern slavery, corruption or bribery, and minimizing or eradicating harmful environmental and social impacts.